Advertisement

Risk Factors Intervention

  • K.G. Manton
  • Igor Akushevich
  • Julia Kravchenko
Part of the Statistics for Biology and Health book series (SBH)

Environmental Risk Factor Contribution to Cancer and Noncancer Diseases

Age–incidence relationships and experimental evidence suggest that cancer is a polygenic multifactorial disease, where the environmental components are important causes of most cancer types (see Chapter 3). A recent study of 90,000 twins (Lichtenstein et al., 2000) showed that the nonshared random environmental effect was the largest factor for all cancers, accounting for 58–82% of the total variation. Various environmental factors, sometimes isolated, but most often in combinations, influence human health, contributing to both cancer and noncancer deaths, including such leading death causes as cardio- and cerebrovascular diseases, cancer, and chronic obstructive pulmonary disease.

Risk factor intervention analysis is used for investigating how systematic changes of age-specific values of parameters, featuring one or group of risk factors, impact life expectancy, mortality, morbidity, and other demographic and...

Keywords

Smoking Prevalence Smoking Rate Conventional Risk Factor Secondary Infertility Population Loss 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Akushevich I., Kravchenko J.S., Manton K.G., 2007. Health based population forecasting: effects of smoking on mortality and fertility. Risk Anal, 27(2):467–482.Google Scholar
  2. Akushevich I., Kulminski A., Manton K., 2005. Life tables with covariates: life tables with covariates: dynamic model for nonlinear analysis of longitudinal data. Math Popul Stud 12(2):51–80.MATHMathSciNetGoogle Scholar
  3. Anderson R.N., 2002. Deaths: leading causes for 2000. Natl Vital Stat Rep 50(16):1–85.Google Scholar
  4. Andreassi M.G., Botto N., Colombo M.G. et al., 2000. Genetic instability and atherosclerosis: can somatic mutations account for the development of cardiovascular disease? Environ Mol Mutagen 35:265–269.Google Scholar
  5. Arabi M., Moshtaghi H., 2005. Influence of cigarette smoking on spermatozoa via seminal plasma. Andrologia 37(4):119–124.Google Scholar
  6. Aragona M., Maisano R., Panetta S. et al., 2000. Telomere length maintenance in aging and carcinogenesis. Int J Oncol 17:981–989.Google Scholar
  7. Ardestani S.K., Inserra P., Solkoff D., Watson R.R., 1999. The role of cytokines and chemokines on tumor progression: a review. Cancer Detect Prev 23:215–225.Google Scholar
  8. Aviram M., 2000. Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases. Free Radic Res 33(Suppl):S85–S97.Google Scholar
  9. Bakker S.J., Gans R.O., 2000. About the role of shear stress in angiogenesis. Cardiovasc Res 45:270–272.Google Scholar
  10. Banks D.A., Fossel M., 1997. Telomeres, cancer, and aging. Altering the human life span. JAMA 278:1345–1348.Google Scholar
  11. Bartsch H., 2000. Studies on biomarkers in cancer etiology and prevention: a summary and challenge of 20 years of interdisciplinary research. Mutat Res 462:255–279.Google Scholar
  12. Blobe G.C., Schiemann W.P., Lodish H.F., 2000. Role of transforming growth factor beta in human disease. N Engl J Med 342:1350–1358.Google Scholar
  13. Brouilette S., Singh R.K., Thompson J.R., Goodall A.H., Samani N.J., 2003. White cell telomere length and risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol 23:842–846.Google Scholar
  14. Bruce W.R., Wolever T.M., Giacca A., 2000. Mechanisms linking diet and colorectal cancer: the possible role of insulin resistance. Nutr Cancer 37:19–26.Google Scholar
  15. Cai H., Harrison D.G., 2000. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87:840–844.Google Scholar
  16. CDC (Centers for Disease Control and Prevention), 1997. Smoking-attributable mortality and years of potential life lost – United States, 1984. MMWR Morb Mortal Wkly Rep 46(20):444–451.Google Scholar
  17. CDC (Centers for Disease Control and Prevention), 2005. Annual smoking-attributable mortality, years of potential life lost, and productivity losses – United States, 1997–2001. MMWR Morb Mortal Wkly Rep 54(25):625–628.Google Scholar
  18. Cerami C., Founds H., Nicholl I. et al., 1997. Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci USA 94:13915–13920.Google Scholar
  19. Chambers J.C., Seddon M.D., Shah S., Kooner J.S., 2001. Homocysteine: a novel risk factor for vascular disease J R Soc Med 94:10–13.Google Scholar
  20. Checkoway H., DiFernando G., Hulka B.S., Mickey D.D., 1987. Medical, lifestyle, and occupational risk factors for prostate cancer. Prostate 10:79–88.Google Scholar
  21. Chen J.Z., Zhang F.R., Tao Q.M., Wang X.X., Zhu J.H., 2004. Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolemia. Clin Sci (Lond) 107:273–280.Google Scholar
  22. Chisolm G.M., Chai Y., 2000. Regulation of cell growth by oxidized LDL. Free Radic Biol Med 28:1697–1707.Google Scholar
  23. Ciardiello F., 2000. Epidermal growth factor receptor tyrosine kinase inhibitors as anticancer agents. Drugs 60(Suppl 1):25–32.Google Scholar
  24. Clemons M., Goss P., 2001. Estrogen and the risk of breast cancer. N Engl J Med 344:276–285.Google Scholar
  25. Coleman W.B., Tsongalis G.J., 1999. The role of genomic instability in human carcinogenesis. Anticancer Res 19:4645–4664.Google Scholar
  26. Collins T., Cybulsky M.I., 2001. NF-kappaB: pivotal mediator or innocent bystander in atherogenesis? J Clin Invest 107:255–264.Google Scholar
  27. Curran S., Murray G.I., 2000. Matrix metalloproteinases: molecular aspects of their roles in tumor invasion and metastasis. Eur J Cancer 36:1621–1630.Google Scholar
  28. DHHS (U.S. Department of Health and Human Services), 2000. Healthy People 2010. With Understanding and Improving Health and Objectives for Improving Health. 2nd edition, Vol. 2. Washington, DC: U.S. Department of Health and Human Services.Google Scholar
  29. DHHS (U.S. Department of Health and Human Services), 2004. The Health Consequences of Smoking. A Report of the Surgeon General U.S. Department of Health and Human Services. Rockville, MD: Public Health Service Office of the Surgeon General. http://www.cdc.gov/tobacco/sgr/sgr_2004/chapters.htm
  30. Dimmeler S., Zeiher A.M., 2000. Endothelial cell apoptosis in angiogenesis and vessel regression. Circ Res 87:434–439.Google Scholar
  31. Djousse L., Myers R.H., Coon H., Arnett D.K., Province M.A., Ellison R.C., 2000. Smoking influences the association between apolipoprotein E and lipids: the National Heart, Lung, and Blood Institute Family Heart Study. Lipids 35(8):827–831.Google Scholar
  32. Doll R., Peto R., Boreham J. et al., 2005. Mortality from cancer in relation to smoking: 50 years observations on British doctors. Br J Cancer 92:426–429.Google Scholar
  33. Dorfman S.F., 2008. Tobacco and fertility: our responsibilities. Fertil Steril 89(3):502–504.MathSciNetGoogle Scholar
  34. Dreyer L., Olsen J.H., 1999. Risk for non-smoking-related cancer in atherosclerotic patients. Cancer Epidemiol, Biomarkers Prev, 8:915–918.Google Scholar
  35. Edelberg J.M., 2002. Auto repair on the aging stem cell superhighway. Sci Aging Knowledge Environ 4 Sept:13. DOI: 10.1126/sageke.2002.35.pe13.Google Scholar
  36. Enstrom J.E., 1984. Smoking and longevity studies. Science 225:878.Google Scholar
  37. Evans W.K., Will B.P., Berthelot J.M., Wolfson M.C., 1995. Estimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM model. Can J Oncol 5:408–419.Google Scholar
  38. Feinleib M., Luoto J., 1984. Longevity of non-smoking men and women. Public Health Rep 99:223.Google Scholar
  39. Fellows J.L., Trosclair A., Adams E.K., Rivera C.C., 2002. Annual smoking-attributable mortality, years of potential life lost, and economic costs – United States, 1995–1999. Morb Mortal Wkly Rep 51(14):300–303.Google Scholar
  40. Feuer E.J., Etzioni R., Cronin K.A., Mariotto A., 2004. The use of modeling to understand the impact of screening on U.S. mortality: examples from mammography and PSA testing. Stat Methods Med Res 13:421–442.MATHMathSciNetGoogle Scholar
  41. Flegal K.M., Troiano R.P., Pamuk E.R., Kuczmarski R.J., Cambell S.M., 1995. The influence of smoking cessation on the prevalence of overweight in the United States. N Engl J Med 333:1165–1170.Google Scholar
  42. Gajalakshmi G.K., Jha P., Ranson K., Nguyen S., 2000. Global patterns of smoking and smoking-attributable mortality. In: Jha P., Chalouka F. (eds.). Tobacco Control in Developing Countries. Oxford: Oxford Medical Publications, pp. 11–40.Google Scholar
  43. George S.J., 2000. Therapeutic potential of matrix metalloproteinase inhibitors in atherosclerosis. Expert Opin Invest Drugs 9:993–1007.Google Scholar
  44. Gerszten R.E., Mach F., Sauty A. et al., 2000. Chemokines, leukocytes, and atherosclerosis. J Lab Clin Med 136:87–92.Google Scholar
  45. Gilbert N., Troitszch K.G., 1999. Simulation for the Social Scientist. Buckingham: Open University Press.Google Scholar
  46. Giovino G.A., Schooley M.W., Zhu B.P., Chrismon J.H., Tomar S.L., Peddicord J.P., Merritt R.K., Husten C.G., Erikson M.P., 1994. Surveillance for selected tobacco use behavior – United States, 1900–1994. Morb Mortal Wkly Rep CDC Surveill Summ 43(3):1–43.Google Scholar
  47. GMWKIII, 1998. Deaths from 282 Selected Causes by 5-year Age Groups, Race and Sex: Each State and the District of Columbia, 1995, 1996, 1997 and 1998. National Center for Health Statistics. http://cdc.gov/nchs/data/mortab
  48. Goldschmidt-Clermont P., Peterson E.D., 2003. On the memory of a chronic illness. Sci Aging Knowledge Environ 12 Nov:8. DOI: 10.1126/sageke.2003.45.re8.Google Scholar
  49. Harach H.R., Williams E.D., 1995. Childhood thyroid cancer in England and Wales. Br J Cancer 72:777–783.Google Scholar
  50. Hatzistamou J., Kiaris H., Ergazaki M., Spandidos D.A., 1996. Loss of heterozygosity and microsatellite instability in human atherosclerotic plaques. Biochem Biophys Res Commun 225:186–190.Google Scholar
  51. Health, United States, 2002. National Center for Health Statistics, http://www.cdc.gov/nchs/products/pubs/pubd/hus/02hustop.htm
  52. Heart Disease and Stroke Statistics, 2005. Update. (American Heart Association, Dallas, TX), at http://www.americanheart.org/downloadable/heart/1105390918119HDSStats2005Update.pdf
  53. Henderson B.E., Bogdanoff E., Gerkins V.R., SooHoo J., Arthur M., 1974. Evaluation of cancer risk factors in a retirement community. Cancer Res 34:1045–1048.Google Scholar
  54. Hermann M., Berger P., 1999. Hormone replacement in the aging male? Exp Gerontol 34:923–933.Google Scholar
  55. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., Finkel T., 2003. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348:593–600.Google Scholar
  56. Holden C., 1983. Can smoking explain ultimate gender gap? Science 221:1034.Google Scholar
  57. Hoyert D.L., Anderson R.N., 2001. Age-adjusted death rates: trend data based on the year 2000 standard population. Natl Vital Stat Rep 49(9):1–6.Google Scholar
  58. Human Mortality Database (HMD), 2006. Internet address: http://www.mortality.org
  59. IARC, 1990. Cancer: Causes, Occurrence, and Control. Vol. 100, Lyon, France: IARC Scientific Publications.Google Scholar
  60. IARC, 2004. Tobacco Smoke and Involuntary Smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 83. Lyon: International Agency for Research on Cancer.Google Scholar
  61. Irani K., 2000. Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res 87:179–183.Google Scholar
  62. Isner J.M., 1999. Cancer and atherosclerosis: the broad mandate of angiogenesis. Circulation 99:1653–1655.Google Scholar
  63. Israels E.D., Israels L.G., 2000. The cell cycle. Oncologist 5:510–513.Google Scholar
  64. Ivanov V.K., Manton K.G., Akushevich I., Gorsky A.I., Korelo A.M., Kravchenko J.S., Maksioutov M.A., Tsyb A.F., 2005. Risk of thyroid cancer after irradiation in children and adults. Curr Oncol 12(2):55–64.Google Scholar
  65. JAMA, 2002. Annual smoking-attributable mortality, years of potential life-lost, and economic costs – United States, 1995–1999. JAMA 287:2355–2356.Google Scholar
  66. Jensen T.K., Joffe M., Scheike T. et al., 2006. Early exposure to smoking and future fecundity among Danish twins. Int J Androl 29(6):603–613.Google Scholar
  67. Jeremy J.Y., Rowe D., Emsley A.M., Newby A.C., 1999. Nitric oxide and the proliferation of vascular smooth muscle cells. Cardiovasc Res 43:580–594.Google Scholar
  68. Joesoef M.R., Beral V., Aral S.O., Rolfs R.T., Cramer D.W., 1993. Fertility and use of cigarettes, alcohol, marijuana and cocaine. Ann Epidemiol, ISSN: 1047-2797, 3(6):592–594.Google Scholar
  69. Jump D.B., Clarke S.D., 1999. Regulation of gene expression by dietary fat. Ann Rev Nutr 19:63–90.Google Scholar
  70. Kerbel R.S., 2000. Tumor angiogenesis: past, present and the near future. Carcinogenesis 21:505–515.Google Scholar
  71. Koohestani N., Chia M.C., Pham N.A., Tran T.T., Minkin S., Wolever T.M., Bruce W.R., 1998. Aberrant crypt focus promotion and glucose intolerance: correlation in the rat across diets differing in fat, n-3 fatty acids and energy. Carcinogenesis 19:1679–1684.Google Scholar
  72. Koyi H., Branden E., Gnarpe J., Gnarpe H., Arnholm B., Hillerdal G., 1999. Chlamydia pneumonia may be associated with lung cancer. Preliminary report on a seroepidemiological study. APMIS 107(9):828–832.Google Scholar
  73. Kravchenko J., Goldschmidt-Clermont P.J., Powell T., Stallard E., Akushevich I., Cuffe M.S., Manton K.G., 2005. Endothelial progenitor cell therapy for atherosclerosis: the philosopher’s stone for an aging population? Sci Aging Knowledge Environ 2005(25):e18.Google Scholar
  74. Kullo I.J., Gau G.T., Tajik A.J., 2000. Novel risk factors for atherosclerosis. Mayo Clin Proc 75(4):369–380.Google Scholar
  75. Kune G.A., Kune S., Watson L-F., 1988. Colorectal cancer risk, chronic illness, operations, and medications: case control results from the Melbourne colorectal cancer study. Cancer Res 48:4399–4404.Google Scholar
  76. Leinonen M., Saikku P., 2000. Infections and atherosclerosis. Scand Cardiovasc J 34:12–20.Google Scholar
  77. Li C., Xu Q., 2000. Mechanical stress-initiated signal transductions in vascular smooth muscle cells. Cell Signal 12:435–445.Google Scholar
  78. Lichtenstein P., Holm N.V., Vercasalo P.K., Iliadou A., Kaprio J., Koskenvuo M., Pukkala E., Skytthe A., Hemminki K., 2000. Environmental and heritable factors in the causation of cancer – analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343(2):78–85.Google Scholar
  79. Littman A.J., White E., Jackson L.A., Thornquist M.D., Gaydos C.A., Goodman G.E., Vaughan T.L., 2004. Chlamydia pneumoniae infection and risk of lung cancer. Cancer Epidemiol Biomarkers Prev 13:1624–1630.Google Scholar
  80. Manole D., Schildknecht B., Gosnell B., Adams E., DerWahl M., 2001. Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. J Clin Endocrinol Metab 86(3):1072–1077.Google Scholar
  81. Manton K.G., Akushevich I., 2003. State variable methods for demographic analysis: a mathematical theory of physiological regeneration and aging. Nonlinear Phenom Complex Syst 6(2):1–15.Google Scholar
  82. Manton K.G., Stallard E., 1988. Chronic disease risk modeling: measurement and evaluation of the risks of chronic disease processes. In the Griffin Series of the Biomathematics of Diseases. London, England: Charles Griffin Limited.Google Scholar
  83. Manton K.G., Stallard E., Singer B.H., 1992. Projecting the future size and health status of the U.S. elderly population. Int J Forecast 8:433–458.Google Scholar
  84. Manton K.G., Stallard E., Woodbury M.A., Dowd J.E., 1994. Time-varying covariates in models of human mortality and aging: Multidimensional generalizations of the Gompertz. J Gerontol 49:B169–B190.Google Scholar
  85. Manton K.G., Yashin A.I., 2000. Mechanisms of Aging and Mortality: Searches for New Paradigms. Odense, Denmark: Odense University Press.Google Scholar
  86. Markle H.V., 1997. Coronary artery disease associated with Helicobacter pylori infection is at least partially due to inadequate folate status. Med Hypotheses 49:282–292.Google Scholar
  87. Marmot M., Elliott P., 2005. Coronary Heart Disease Epidemiology. From Aetiology to Public Health. 2nd edition. New York: Oxford University Press, p. 932.Google Scholar
  88. Marnett L.J., 2000. Oxyradicals and DNA damage. Carcinogenesis 21:361–370.Google Scholar
  89. Martin J.A., Hamilton B.E., Ventura S.J., 2001. Births: preliminary data for 2000. Natl Vital Stat Rep. 49(5):1–20.Google Scholar
  90. Martin J.A., Hamilton B.E., Ventura S.J., Menacker F., Park M.M., Sutton P.D., 2002b. Births: final data for 2001. Natl Vital Stat Rep 51(2):1–102.Google Scholar
  91. Martin J.A., Park M.M., Sutton P.D., 2002a. Births: preliminary data for 2001. Natl Vital Stat Rep 50(10):1–20.Google Scholar
  92. Maxwell S.R., 1998. Women and heart disease. Basic Res Cardiol 93(Suppl 2):79–84.Google Scholar
  93. Mayo M.W., Baldwin A.S., 2000. The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance. Biochim Biophys Acta 1470:M55–M62.Google Scholar
  94. McCully K.S., 1994. Chemical pathology of homocysteine. II. Carcinogenesis and homocysteine thiolactone metabolism. Ann Clin Lab Sci 24:27–59.Google Scholar
  95. Miller G.H., Gerstein D.R., 1983. The life expectancy of non-smoking men and women. Public Health Rep 98:343–349.Google Scholar
  96. Minino A.M., Arias E., Kochanek K.D., Murphy S.L., Smith B.L., 2002. Deaths: final data for 2000. Natl Vital Stat Rep 50(15):1–119.Google Scholar
  97. Misra A., 2000. Risk factors for atherosclerosis in young individuals. J Cardiovasc Risk 7:215–229.Google Scholar
  98. MMWR, 2005. Annual smoking-attributable mortality, years of potential life lost, and productivity losses – United States, 1997–2001. MMWR 54(25):625–628.Google Scholar
  99. MMWR, 2006. Tobacco use among adults – United States, 2005. MMWR 55(42):1145–1148.Google Scholar
  100. Mokdad A.H., Marks J.S., Stroup D.F., Gerberding J.I., 2004. Actual causes of death in the United States, 2000. JAMA 291(10):1238–1245.Google Scholar
  101. Molarius A., Seidell J.C., Kuulasmaa K., Dobson A.J., Sans S., 1997. Smoking and relative body weight: an international perspective from the WHO MONICA project. J Epidemiol Community Health 51:252–260.Google Scholar
  102. Moore M.A., Tsuda H., 1998. Chronically elevated proliferation as a risk factor for neoplasia. Eur J Cancer Prev 7:353–385.Google Scholar
  103. Morre S.A., Stooker W., Lagrand W.K. et al., 2000. Microorganisms in the etiology of atherosclerosis. J Clin Pathol 53:647–654.Google Scholar
  104. Mostafa T., Tawadrous G., Roaia M.M. et al., 2006. Effect of smoking on seminal plasma ascorbic acid in infertile and fertile males. Andrologia 38(6):221–224.Google Scholar
  105. Neugut A.I., Jacobson J.S., Ghada S., Sherif G., Ahsan H., Garbowski G.C., Waye J., Forde K.A., Treat M.R., 1995. Coronary artery disease and colorectal neoplasia. Dis Colon Rectum 38:873–877.Google Scholar
  106. Neugut A.I., Rosenberg D.J., Ahsan H., Jakobson J.S., Wahid N., Hagan M., Rahman M.I., Khan Z.R., Chen L., Pablos-Mendez A., Shea S., 1998. Association between coronary heart disease and cancers of the breast, prostate, and colon cancer. Cancer Epidemiol Biomarkers Prev 7:869–873.Google Scholar
  107. Newby A.C., Zaltsman A.B., 2000. Molecular mechanisms in intimal hyperplasia. J Pathol 190:300–309.Google Scholar
  108. Niho N., Takahashi M., Kitamura T., Shoji Y., Itoh M., Noda T., Sugimura T., Wakabayashi K., 2003a. Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferators-activated receptor ligands. Cancer Res 63:6090–6095.Google Scholar
  109. Niho N., Takahashi M., Shoji Y., Takeuchi Y., Matsubara S., Sugimura T., Wakabayashi K., 2003b. Dose-dependent suppression of hyperlipidemia and intestinal polyp formation in Min mice by pioglitazone, a PPAR gamma ligand. Cancer Sci 94:960–964.Google Scholar
  110. Nugent M.A., Iozzo R.V., 2000. Fibroblast growth factor-2. Int J Biochem Cell Biol 32:115–120.Google Scholar
  111. O’Brien E.R., Urieli-Shoval S., Garvin M.R. et al., 2000. Replication in restenotic atherectomy tissue. Atherosclerosis 152:117–126.Google Scholar
  112. O’Hara P., Connett J.E., Lee W.W., Nides M., Murray R., Wise R., 1998. Early and late weight gain following smoking cessation in the lung health study. Am J Epidemiol 148:821–830.Google Scholar
  113. Okura Y., Brink M., Itabe H. et al., 2000. Oxidized low-density lipoproteins is associated with apoptosis of vascular smooth muscle cells in human atherosclerotic plaques. Circulation 102:2680–2686.Google Scholar
  114. Parsons R., Myeroff L.L., Liu B. et al., 1995. Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res 55:5548–5550.Google Scholar
  115. Peate I., 2005. The effects of smoking on the reproductive health of men. Br J Nurs 14(7):362–366.Google Scholar
  116. Pekkanen J., Manton K.G., Stallard E., Nissinen A., Karvonen M.J., 1992. Risk factor dynamics, mortality, and life expectancy differences between eastern and western Finland: the Finnish cohorts of the seven countries study. Int J Epidemiol 21:406–419.Google Scholar
  117. Powles J.W., Sanz M.A., 1996. Vascular mortality not attributable to smoking trends in European populations since the 1950s. In: The XIV International Scientific Meeting of the International Epidemiological Association: global health in a changing environment. Program and abstracts. Nagoya: International Epidemiological Association, p. 189.Google Scholar
  118. Ramlau-Hansen C.H., Thulstrup A.M., Aggerholm A.S. et al., 2007. Is smoking a risk factor for decreased semen quality? A cross-sectional analysis. Hum Reprod 22(1):188–196.Google Scholar
  119. Ramsey S.D., McIntosh M., Etzioni R., Urban N., 2000. Simulation modeling of outcomes and cost effectiveness. Hematol Oncol Clin North Am 14(4):925–938.Google Scholar
  120. Rauscher F.M., Goldschmidt-Clermont P.J., Davis B.H., Wang T., Gregg D., Ramaswami P., Pippen A.M., Annex B.H., Dong C., Taylor D.A., 2003. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 29, 457–463.Google Scholar
  121. Reed J.C., 2000. Apoptosis and cancer: strategies for integrating programmed cell death. Semin Hematol 37(Suppl 7):9–16.Google Scholar
  122. Robbins W.A., Elashoff D.A., Xun L., Jia J., Li N., Wu G., Wei F., 2005. Effect of lifestyle exposures on sperm aneuploidy. Cytogenet Genome Res 111(3–4):371–377.Google Scholar
  123. Rodu B., Stegmayr B., Nasic S., Cole P., Asplund K., 2004. The influence of smoking and smokeless tobacco use on weight amongst men. J Intern Med 255:102–107.Google Scholar
  124. Ron E., Kleinerman R.A., Boice J.D., LiVolsi V.A., Flannery J.T., Fraumen J.F., 1987. A population-based case–control study of thyroid cancer. J Natl Cancer Inst 79:1–12.Google Scholar
  125. Ross J.S., Stagliano N.E., Donovan M.J., Breitbart R.E., Ginsburg G.S., 2001. Atherosclerosis and cancer. Common molecular pathways of disease development and progression. Ann NY Acad Sci 947:271–293.Google Scholar
  126. Ruef J., Peter K., Nordt T.K. et al., 1999. Oxidative stress and atherosclerosis: its relationship to growth factors, thrombus formation and therapeutic approaches. Thromb Haemost 82:32–37.Google Scholar
  127. Sasayama S., Okada M., Matsumori A., 2000. Chemokines and cardiovascular diseases. Cardiovasc Res 45:267–269.Google Scholar
  128. Schwartz S.M., Murry C.W., 1998. Proliferation and the monoclonal origins of atherosclerotic lesions. Annu Rev Med 49:437–460.Google Scholar
  129. Sempos C.T., Durazo-Arvizu R., McGee D.L., Cooper R.S., Prewitt T.E., 1998. The influence of cigarette smoking on the association between body weight and mortality. The Framingham Heart Study revisited. Ann Epidemiol 8(5):289–300.Google Scholar
  130. Sepaniak S., Forges T., Monnier-Barbarino P., 2005. Consequences of cigarette smoking on male fertility. J Gynecol Obstet Biol Reprod (Paris) 34(1):3S102–3S111.Google Scholar
  131. Sepaniak S., Forges T., Monnier-Barbarino P., 2006. Cigarette smoking and fertility in women and men. Gynecol Obstet Fertil 34(10):945–949.Google Scholar
  132. Shackelford R.E., Kaufmann W.K., Paules R.S., 2000. Oxidative stress and cell cycle checkpoint function. Free Radic Biol Med 28:1387–1404.Google Scholar
  133. Shi L., Macinko J., Starfield B., Politzer R., Xu J., 2005. Primary care, race, and mortality in U.S. States. Soc Sci Med 61(1):65–75.Google Scholar
  134. Slater S., Oliver R.T., 2000. Testosterone: its role in development of prostate cancer and potential risk from use as hormone replacement therapy. Drugs Aging 17:431–439.Google Scholar
  135. Smith R.A., Glynn T.J., 2000. Epidemiology of lung cancer. Radiol Clin North Am 38:453–470.Google Scholar
  136. Smoking and Tobacco Control Monograph, 1997. No. 6, NIH Pub. No. 97-4213.Google Scholar
  137. Strong J.P, Malcom G.T., McMahan C.A., Tracy R.E., Newman III W.P., Herderick E.E., Cornhill J.F., 1999. Prevalence and extent of atherosclerosis in adolescents and young adults: Implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA 281:727–735.Google Scholar
  138. Tabuchi M., Kitayama J., Nagawa H., 2006. Hypertriglyceridemia is positively correlated with the development of colorectal tubular adenoma in Japanese men. World J Gastroenterol 12(8):1261–1264.Google Scholar
  139. Tardif J.C., 2000. Insights into oxidative stress and atherosclerosis. Can J Cardiol 16(Suppl):2D–4D.Google Scholar
  140. Thambyrajah J., Townsend J.N., 2000. Homocysteine and atherothrombosis: mechanisms for injury. Eur Heart J 21:967–974.Google Scholar
  141. Thompson M.M., Garland C., Barrett E., Khaw K., Friedlander N.J., Wingard D.L., 1988. Heart disease risk factors, diabetes, and prostatic cancer in an adult community. Am J Epidemiol 129:511–517.Google Scholar
  142. TIPS (Tobacco Information and Prevention Source), November 2005. Smoking Prevalence Among U.S. Adults. URL: http//www.cdc.gov/tobacco/research_data/adults_prev/prevail.htm
  143. Tunstall-Pedoe H. (ed.), 2003. Monica: Monograph and Multimedia Sourcebook. Geneva, Switzerland: World Health Organization.Google Scholar
  144. Tzonou A., Hsich C.-C., Trichopoulos D., Aravandinos D., Kalandidi A., Margaris D., Goldman M., Toupadaki N., 1993. Induced abortions, miscarriages and tobacco smoking as risk factors for secondary infertility. J Epidemiol Community Health 47:36–39.Google Scholar
  145. Vainio H., Bianchini F., 2002. IARC Handbooks of Cancer Prevention. Vol. 6: Weight Control and Physical Activity. Lyon, France: IARC Press.Google Scholar
  146. Van den Akker-van Marle M.E., van Ballegooijen M., van Oortmarssen G.J., Boer R., Habbema J.D., 2002. Cost-effectiveness of cervical cancer screening: comparison of screening policies. J Natl Cancer Inst 94:193–204.Google Scholar
  147. Vanness D.J., Tosteson A.N., Gabriel S.E., Melton L.J., 2005. The need for microsimulation to evaluate osteoporosis interventions. Osteoporos Int 16(4):353–358.Google Scholar
  148. Ventura S.J., Hamilton B.E., Sutton P.D., 2003. Revised birth and fertility rates for the United States, 2000 and 2001. Natl Vital Stat Rep 51(4):1–18.Google Scholar
  149. Waldron I., 1986. The contribution of smoking to sex differences in mortality. Public Health Rep 101(2):163–173.Google Scholar
  150. Wallenfeldt K., Hulthe J., Bokemark L., Wikstrand J., Fagerberg B., 2001. Carotid and femoral atherosclerosis, cardiovascular risk factors and C-reactive protein in relation to smokeless tobacco use or smoking in 58 year old men. J Intern Med 250:492–501.Google Scholar
  151. Wang X.L., 2000. Cigarette smoking. DNA variants in endothelial nitric oxide synthase gene and vascular disease. Contrib Nephrol 130:53–67.Google Scholar
  152. Wang J.M., Deng X., Gong W., Su S., 1998. Chemokines and their role in tumor growth and metastasis. J Immunol Methods 220:1–17.Google Scholar
  153. Witteman J.C.M., Grobbee D.E., Valkenburg H.A., van Hemert A.M., Stijnen T., Burger H., Hofman A., 1994. J-shaped relation between change in diastolic blood pressure and aortic atherosclerosis. Lancet 343:504–507.Google Scholar
  154. Wolf D., 2001. The role of microsimulation in longitudinal data analysis. Can Stud Popul 28:165–179.Google Scholar
  155. Wolfson M.C., 1994. POHEM – a framework for understanding and modeling the health of human populations. World Health Stat Q 47:157–176.Google Scholar
  156. Wood D., 2001. Established and emerging cardiovascular risk factors. Am Heart J 141:49–57.Google Scholar
  157. Woodbury M.A., Manton K.G., 1977. A random walk model of human mortality and aging. Theor Popul Biol 11:37–48.MathSciNetGoogle Scholar
  158. Woodbury M.A., Manton K.G., 1983a. A mathematical model of the physiological dynamics of aging and correlated mortality selection. I. Theoretical development and critiques. J Gerontol 38:398–405.Google Scholar
  159. Woodbury M.A., Manton K.G., 1983b. A theoretical model of the physiological dynamics of circulatory disease in human populations. Human Biol 55:417–441.Google Scholar
  160. Woodbury M.A., Manton K.G., Stallard E., 1981. Longitudinal models for chronic disease risk: an evaluation of logistic multiple regression and alternatives. Int J Epidemiol 10:187–197.Google Scholar
  161. Yamada K., Araki S., Tamura M., Sakai I., Takahashi Y., Kashihara H., Kono S., 1998. Relation of serum total cholesterol, serum triglycerides and fasting plasma glucose to colorectal carcinoma in situ. Int J Epidemiol 27:794–798.Google Scholar
  162. Yancopoulos G.D., Davis S., Gale N.W. et al., 2000. Vascular-specific growth factors and blood vessel formation. Nature 407:242–248.Google Scholar
  163. Zalba G., Beaumont J., San Jose G. et al., 2000. Vascular oxidant stress: molecular mechanisms and pathophysiological implications. J Physiol Biochem 56:57–64.Google Scholar
  164. Zettler M.E., Pierce G.N., 2000a. Cell cycle proteins and atherosclerosis. Herz 25:100–107.Google Scholar
  165. Zettler M.E., Pierce G.N., 2000b. Growth-promoting effects of oxidized low density lipoprotein. Can J Cardiol 17:73–79.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • K.G. Manton
    • 1
  • Igor Akushevich
    • 1
  • Julia Kravchenko
    • 1
  1. 1.Duke UniversityDurhamUSA

Personalised recommendations